Open Access

Published by Open AIRPublication Date: 2014Download: Optimising Benefits from Publicly Funded Research (323) This 2014 Briefing Note highlights Open AIR research findings on apparent disconnects between...

Authored by: Jeremy de Beer Abstract: Governments have long been interested in making intellectual property (IP) policy based on sound evidence. There is a large...

Authored by: Njoku Ola Ama and Francis Nathan Okurut Abstract: This study explores the adoption, by micro, small, and medium-sized enterprises (MSMEs) in Botswana, of...

Par Abdelhamid Benhmade En réponse à l’invitation de Cités et Gouvernements Locaux Unis d’Afrique (CGLU Afrique), j’ai eu la possibilité d’assister à la 8èmeédition du...

This 2013 book is the product of three years of literature reviews, expert interviews and scenario-building exercises by the Open AIR network. The authors trace the contours of knowledge and innovation in Africa from the founding civilisations to today’s current realities, and then set out the drivers of change that can be expected to shape innovation systems on the continent between now and the year 2035.

By Michael Dao On March 28th, 2019, the University of Ottawa hosted the Shifting Horizons: Managing Your Research Data Conference, a day-long series of workshops for researchers. I...

Jeremy de Beer, Chris Armstrong, Chidi Oguamanam et Tobias Schonwetter Date de publication : septembre 2017 Télécharger: Chapitre 16 : La propriété intellectuelle...

Authored by: Oluseye Oladayo Jegede and Olubukola Esther Jegede Abstract: This study contributes to the growing literature on innovation capability in the informal sector in...

By Uchenna Felicia Ugwu Achieving global food security will require innovation. Processes like plant phenotyping and technologies like digital imaging are examples of innovation that...

Edited by: Chidi Oguamanam. When the oral history of a medicinal plant as a genetic resource is used to develop a blockbuster drug, how is the contribution of Indigenous Peoples recognized in research and commercialization? What other ethical, legal, and policy issues come into play? Is it accurate for countries to self-identify as users or providers of genetic resources?